Formaldehyde

Formaldehyde

SCHEMBL6813353

[3H]C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL12363404 0.83
Formaldehyde SCHEMBL16922655 0.72
Formaldehyde SCHEMBL8330944 0.71
Formaldehyde SCHEMBL268 0.71
Formaldehyde SCHEMBL1347887 0.71
Formaldehyde SCHEMBL13582711 0.71
Formaldehyde SCHEMBL6977718 0.71
Formaldehyde SCHEMBL12190180 0.71
Formaldehyde SCHEMBL3907789 0.71
Formaldehyde SCHEMBL23581487 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130303497-A1 DEUTERATED 5-HT1A RECEPTOR AGONISTS CONRIG PHARMA APS (DK) 2013-11-14 US disclosed
US-20130296279-A1 SUBSTITUTED TETRACYCLINES CONCERT PHARMACEUTICALS INC. 2013-11-07 US disclosed
US-20130274480-A1 MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-10-17 US disclosed
US-20130256640-A1 ASSEMBLY AND ELECTRONIC DEVICES INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-10-03 US disclosed
US-20130121912-A1 MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER BAYLOR COLLEGE OF MEDICINE (US) 2013-05-16 US disclosed
US-20130089526-A1 Methods for Using Synthetic Triterpenoids in the Treatment of Bone or Cartilage Diseases or Conditions TRUSTEES OF DARTMOUTH COLLEGE (US) 2013-04-11 US disclosed
US-20130084561-A1 BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY COULL JAMES M (US) 2013-04-04 US disclosed
US-8389752-B2 Preparation of alicyclic diepoxides Peomerus LLC (US) 2013-03-05 US disclosed
US-8314137-B2 Monocyclic cyanoenones and methods of use thereof TRUSTESS OF DARTMOUTH COLLEGE (US) 2012-11-20 US disclosed
US-8288560-B2 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments IPSEN PHARMA S.A.S. (FR) 2012-10-16 US disclosed
US-20070154899-A1 Biodetection by nucleic acid-templated chemistry ENSEMBLE THERAPEUTICS CORPORATION 2007-07-05 US disclosed
US-20070141397-A1 TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE COMPOUND IDEMITSU KOSAN CO., LTD (JP) 2007-06-21 US disclosed
US-20070123715-A1 Method of using rhodium quinonoid catalysts BROWN UNIVERSITY 2007-05-31 US disclosed
US-20070117981-A1 Rhodium quinonoid catalysts BROWN UNIVERSITY 2007-05-24 US disclosed
US-20070108891-A1 METAL-COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-05-17 US disclosed
US-7205427-B2 Cross-coupling synthesis of alkyl (dialkylphenyl) indenes BOULDER SCIENTIFIC COMPANY (US) 2007-04-17 US disclosed
US-20070009760-A1 Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device INOUE TETSUYA 2007-01-11 US disclosed
EP-1206484-B1 ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR THEIR SYNTHESIS AGOURON PHARMA (US) 2004-10-06 EP disclosed
US-6534530-B1 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors AGOURON PHARMACEUTICALS, INC. 2003-03-18 US disclosed
CN-1372566-A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis AGOURON PHARMA (US) 2002-10-02 CN disclosed